Assistant Director of Drugs Control in Zone-V, Chennai, has temporarily suspended the drug license of CPD Pharma Private Limited, a company wholly owned by Entero Healthcare Solutions Limited.
The suspension is for seven days, from February 26, 2024, to March 3, 2024, due to violations of Section 18(c) of the Drugs and Cosmetics Act, 1940, along with Rule 65(9)(b) of Drugs and Cosmetics Rules, 1945, and the license conditions.
The violation is related to Section 18(c) of the Drugs and Cosmetics Act 1940 and Rule 65(9)(b) of Drugs and Cosmetic Rules 1945, in connection with CPD’s business activities.
The impact on Entero’s financial and operational activities is minimal. CPD’s operations were already downsized for operational efficiency in the region, with external customer supplies discontinued after January 31, 2024.
CPD’s revenue contributes only 0.17% (excluding intercompany sales) to Entero’s total consolidated revenue as of the half-year ending September 30, 2023.
🚀
⚡ Prime
Enjoy an Ad-Free Reading Experience
Plus 100+ screener conditions, historical signal analysis, DIY stock screening, FII/DII data & more.
I’m Abhishek Sharma, an Advocate based in Delhi, entrepreneur, investor, and founder of BigBreakingWire.
I am an enrolled Advocate with a strong interest in entrepreneurship, media, and technology. I founded BigBreakingWire, a digital news platform covering breaking news, business, financial markets, companies, and important developments in India and around the world.
I also have a software company and take an active interest in technology, software, AI, digital products, and new business ideas.
As an investor, I’m interested in discovering and investing in promising businesses and startups. I look for good ideas, strong founders, practical business models, and opportunities with long-term potential.
I enjoy building businesses, learning about new industries, and connecting with people who are working on interesting ideas and opportunities.
Advocate | Entrepreneur | Investor | Founder & Editor-in-Chief, BigBreakingWire
Last reviewed by Abhishek Sharma on August 31, 2026
Disclaimer:
BigBreakingWire provides news and informational content for general educational purposes only. The information presented on this website does not constitute financial, investment, tax, or legal advice. Readers should consult qualified professionals before making any financial decisions. BigBreakingWire, its authors, and editors are not responsible for any financial losses or damages arising from the use of information on this site.
Discussion
Share your take — react and comment in seconds, no login needed.
